赞努布鲁丁尼布:过去,现在和未来
Constantine S Tam1, Javier L Muñoz2, John F Seymour3
1Alfred Hospital and Monash University, Melbourne, VIC, Australia. constantine.tam@alfred.org.au.
Blood cancer journal
|September 11, 2023
概括
赞努布鲁丁尼布是下一代布鲁顿氨酸激酶 (BTK) 抑制剂,在B细胞恶性瘤中提供了增强的特异性和改善患者的治疗结果. 本综述详细介绍了其从分子设计到临床应用的发展.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 布鲁顿氨酸激酶 (BTK) 抑制剂已经彻底改变了B细胞恶性瘤的治疗方法,而易布鲁替尼是开创性的治疗方法.
- 在BTK抑制剂之前,化疗免疫疗法是标准的,提供有限的疗效和安全性.
- 了解BTK的作用对于开发有针对性的疗法至关重要.
研究的目的:
- 审查扎努布鲁丁尼布的发展,这是下一代BTK抑制剂.
- 突出其分子设计,临床前优势和临床疗效.
- 为了展示B细胞恶性瘤治疗的进步.
主要方法:
- 分子设计的结构-活动关系策略.
- 临床前研究评估特异性,酶性和药用动力学特性.
- 临床试验评估B细胞恶性瘤的安全性和有效性.
主要成果:
- 在临床前研究中,赞努布鲁丁尼布与伊布鲁丁尼布相比,显示出更高的特异性和生物可用性.
- 临床试验显示在B细胞恶性瘤中具有显著的活性和改善的安全性.
- 现在,扎努布鲁丁尼布已被批准用于全球各种B细胞恶性瘤.
结论:
- 赞努布鲁丁尼布代表了BTK抑制剂治疗B细胞恶性瘤的重大进展.
- 它的发展强调了从长椅到床边的多学科研究的重要性.
- 持续的研究正在探索扎努布鲁丁尼布在组合疗法和其他血液疾病中的潜力.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Drug Administration and Therapy Phases: Overview
518
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
518


